Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2025-12-24 @ 7:04 PM
NCT ID: NCT05023057
Eligibility Criteria: Inclusion Criteria: * 60 to 85 years of age * Having at least one modifiable dementia risk factor * Complaints of cognitive decline by a participant or informant * A performance score that is lower than 1.0 standard deviations below the age-, and education-adjusted normative means for one or more of the delayed recall, naming, visuoconstruction, attention, and executive function tests * MMSE Z score ≥ - 1.5 * Independent activities of daily living * Being able to use the tablet PC through education, or having a person who can help a participant use the tablet PC. * Having a reliable informant who could provide investigators with the requested information * Provide written informed consent Exclusion Criteria: * Major psychiatric illness such as major depressive disorders * Dementia * Other neurodegenerative disease (e.g., Parkinson's disease) * Malignancy within 5 years * Cardiac stent or revascularization within 1 year * Serious or unstable symptomatic cardiovascular disease * Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease * Severe loss of vision, hearing, or communicative disability * Any conditions preventing cooperation as judged by the study physician * Significant laboratory abnormality that may result in cognitive impairment * Illiteracy * Unable to participate in exercise program safely * Coincident participation in any other intervention trial
Healthy Volunteers: False
Sex: ALL
Minimum Age: 60 Years
Maximum Age: 85 Years
Study: NCT05023057
Study Brief:
Protocol Section: NCT05023057